Definitive Contract 75A50118C00015
Award Date
7/12/18
Potential Completion Date
10/31/26
Potential Value
$50M
Awardee
Spero Therapeutics, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Sharing
Place of Performance
Cambridge, MA 02139, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
<p>This is a federal contract award valued at $237,994,127.86, awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Hoffmann-La Roche Inc. The contract is for the "COMBATING MULTI-DRUG RESISTANCE AND ADDRESSING EMERGING BACTERIAL THREATS: DISCOVERY, CLINICAL DEVEL" program, with a period of performance through September 30, 2027. The contract is a definitive, cost-no-fee contract and does not have a set-aside designation.</p>
This is a $4,590,862.00 cost-plus-fixed-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Sorrento Therapeutics, Inc., a small disadvantaged business. The contract is for the "DEVELOPMENT OF IN VITRO FOR BIODEFENSE, ANTIMICROBIAL RESISTANT (AMR) INFECTIONS AND EMERGING INFECTIOUS DISEASES", which was a Broad Agency Announcement (BAA) research area. The contract has a period of performance through May 2, 2025...
This $18,274,778 definitive contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to AN2 Therapeutics, Inc. The contract supports the development of epetraborole as a novel therapeutic for melioidosis and additional antimicrobial resistant bacterial biothreat pathogens. This award was issued under a Broad Agency Announcement (BAA) that also sought proposals for advanced vaccine and diagnostic development against biodefense and emerging...
This federal contract award is an Other Transaction Agreement between Global Life Sciences Solutions USA LLC and the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency. The $72,104,359.91 cost-sharing agreement is focused on expanding capacity for COVID-19 response and supporting public health emergencies, with a completion date of December 31, 2038. Global Life Sciences Solutions USA LLC, a for-profit limited liability company and wholly owned subsidiary...
This is a $468,104.64 firm-fixed-price contract awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Cytovale Inc., a small disadvantaged business based in San Francisco, California. The contract is for research and development related to the clinical validation of an at-home, deep-learning based sepsis monitoring system. This contract was awarded under ASPR's Biomedical Advanced Research and Development...
This federal contract award to Clarivate Analytics (Us) LLC (Clarivate) is for research and development to develop medical countermeasures for chemical threats using drug repositioning. The $749,201 firm-fixed-price contract was awarded on September 20, 2021 by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the Department of Health and Human Services. The contract has a period of performance through February 28, 2023 and was issued under a...
This is a $749,999.01 firm fixed-price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Red Queen Therapeutics Inc., a self-certified small disadvantaged business. The contract is for research and development of a rapid response platform for the development of a pan-influenza virus fusion inhibitor for the treatment of influenza virus infections. This contract is not set aside and has an ultimate completion date of...
This federal contract award, with identification number HHSO100201500031P, was issued by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Speer Operational Technologies, LLC, a small business veteran-owned limited liability company. The contract, with a ceiling value of $5,500.00, is for the procurement of "VARIOUS EQUIPMENT FOR TAC MED" under the ASPR-15-07080 solicitation. The contract is a firm-fixed-price purchase order with a...
This is a $76,986,068.46 cost-no-fee definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to T2 Biosystems, Inc. to advance the development of rapid, high-throughput, multiplexed detection of biothreat species identification and resistance genes using T2MR as a rapid countermeasure to diagnose bacterial biothreat pathogens and bacterial antibiotic resistance threats. The contract supports the preparedness mission and priorities of the HHS...
This federal contract award was issued by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS). The contract was awarded to Cyberpro JV LLC, doing business as Public Health Emergency Solutions, an SBA-certified 8(a) joint venture minority-owned small disadvantaged business. The $1,320,489.60 firm fixed price delivery order contract will provide professional staffing and IT services to support...